| Tkeyah Evans, | |
|
801 Corporate Center Dr Ste 210, Pomona, CA 91768-2627 | |
| (909) 618-0974 | |
| Not Available |
| Full Name | Tkeyah Evans |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Family |
| Location | 801 Corporate Center Dr Ste 210, Pomona, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346970985 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TF0000X | Psychologist - Family | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tkeyah Evans, 801 Corporate Center Dr Ste 210, Pomona, CA 91768-2627 Ph: () - | Tkeyah Evans, 801 Corporate Center Dr Ste 210, Pomona, CA 91768-2627 Ph: (909) 618-0974 |
News Archive
Ampio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, whose lead drugs treat inflammatory diseases, including osteoarthritis and complications of Diabetes Mellitus such as diabetic macular edema (and others) announced today that it's CRO has completed analysis of the primary end point in the Optina clinical trial for DME conducted at St Michael Diabetes Hospital in Toronto Canada.
Senesco Technologies, Inc. announced today that Catherine Taylor, one of the Company's funded researchers, will be presenting pre-clinical stability and biological activity data on SNS-01, Senesco's multiple myeloma drug candidate, at the 2009 American Association for Cancer Research (AACR)-National Cancer Institute (NCI)-European Organization for Research and Treatment of Cancer (EORTC) Molecular Targets and Cancer Therapeutics Conference.
BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announces the approval from the French Drug Agency (AFFSSaPS) to enter Phase II clinical trial for clonidine Lauriad® in radiotherapy and chemotherapy-induced oral mucositis and the approval from Danish and Slovene Agencies to enter Phase I clinical trial for AMEPTM in invasive melanoma.
Teva Pharmaceutical Industries Ltd. announced today that Teva-KOWA Pharma Co., Ltd., the Company's joint venture in Japan with KOWA Company, Ltd., has signed a definitive agreement to acquire a majority of the outstanding shares of Taisho Pharmaceutical Industries, Ltd.
Independent studies done by universities and corporations have illustrated a remarkable increase in the yield of viable stem cells after cryopreservation using AAGP™ in the freeze-thaw process. One future approach to increasing diabetics' insulin production is related to an ability to convert their stem cells into islet cells for transplantation. The feasibility of this procedure is dependent upon the amount of functioning islet cells that can be derived from the patient's stem cells. This is where AAGP™ can make a very beneficial contribution.
› Verified 7 days ago
Dr. Kaseja Kang, PH D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3530 Pomona Blvd, Pomona, CA 91768 Phone: 909-595-1221 | |
Mr. Stanley E Lunde, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3530 Pomona Blvd, Pomona, CA 91768 Phone: 909-595-1221 | |
Dr. David A Smith, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3530 West Pomona Blvd, Pomona, CA 91769 Phone: 909-595-1221 | |
Ana I Pleitez, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1642 Club Dr, Pomona, CA 91768 Phone: 909-576-5444 | |
Nancy Farrell, PSYD DRPH Psychologist Medicare: Not Enrolled in Medicare Practice Location: 255 E Bonita Ave, Pomona, CA 91767 Phone: 909-596-7733 | |
Dr. Patricia Faye Wallace-burke, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2008 N Garey Ave, Pomona, CA 91767 Phone: 909-623-6131 Fax: 909-865-9281 |